Endogenous histamine reduces plasma insulin-like growth factor I via H 1 receptor-mediated pathway in the rat

Author： Liao W.   Rudling M.   Moller C.   Angelin B.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.374, Iss.3, 1999-06, pp. : 471-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The insulin-like growth factor-I receptor as a target for cancer therapy

By Baserga Renato  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 753-768

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like growth factor-I receptor – a potential therapeutic target in medulloblastomas

By Reiss Krzysztof  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 539-544

Informa Healthcare

Access to resources Recommend Favorite

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP   Macaulay Valentine M  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-Like Growth Factor I: Implications in Aging

By Arvat E.   Broglio F.   Ghigo E.  

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 29-40

Adis International

Access to resources Recommend Favorite